Thank you for your interest in the ‘DIRect Experience with Choice of Therapy for NeuroEndocrine Tumours’ or DIRECT NETs study.
DIRECT NETs is an international study that seeks to improve patient-centered treatment decision making. Using an innovative survey that involves making a series of choices between potential treatments with difference characteristics, the study will enhance doctors’ understanding of why different people prefer the various medications that are used to treat NETs.
DIRECT-NETs is an online, self-administered anonymous survey that takes less than 15 minutes to complete. It is open to:
- NET patients
- Families and friends of NET patients who have been involved in their journey
- Healthcare professionals involved in the care of NET patients
The DIRECT NETs study will launch on September 24th, 2020 and the survey will be available through November 5th, 2020.
DIRECT NETs is a study being conducted under the auspices of CommNETS, the Commonwealth Neuroendocrine Tumour Collaboration.
You can find out more about the study, and self-enroll if you are interested, by clicking on the link below: